Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati - Gilde Healthcare

Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati

June 9, 2023
Utrecht (The Netherlands)

Gilde Healthcare, a leading transatlantic investment firm specialized in the healthcare sector, is pleased to announce the addition of Besmire Ahmati to its team as Associate Investor Relations and Fundraising.

In this new role, Besmire will focus on supporting Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising and communications efforts. With over 5 years of experience in financial services and more recently as an LP investor, Besmire brings valuable expertise to Gilde Healthcare.

“We are pleased to welcome Besmire to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “Her experience with institutional investors such as PGGM and FMO, strong industry relationships, and entrepreneurial mindset will help in building out our fundraising strategy and investor relationships.”

Prior to joining Gilde Healthcare, Besmire was part of the PGGM Private Equity team as a Junior Investment Manager investing in a global portfolio of private equity funds and co-investments. Prior to that, Besmire worked as a portfolio analyst in distressed assets transactions in private markets for FMO – the Dutch Entrepreneurial Development Bank. She began her career at Van Lanschot Kempen as an investment graduate.

“I am honored to be a part of Gilde Healthcare’s exceptional team and contribute to the firm’s continued success. I look forward to collaborating with our existing and prospective investors, delivering exceptional service, and fostering long-term partnerships with our stakeholders.” said Ahmati.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at

Gilde Healthcare company Ablative Solutions demonstrates Significant Reduction in Blood Pressure meeting its primary endpoint in Pivotal Trial

Ablative Solutions, Inc., announced that primary trial results from the TARGET BPI Pivotal Trial, evaluating alcohol-mediated renal denervation with the Peregrine SystemTM Kit, were presented as a Late-Breaking Clinical Trial at the American College of...
April 11, 2024

Gilde Healthcare company ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, today announced completion of enrollment of the ProVIDE pivotal clinical trial to evaluate...
March 21, 2024

Gilde Healthcare sells RAD-x to a consortium of Swiss Life Asset Managers and Vesper Infrastructure Fund I

Gilde Healthcare’s Private Equity Fund (“Gilde Healthcare”), a specialized healthcare investor, has reached a binding agreement to sell its majority stake in RAD-x to a consortium of Swiss Life Asset Managers and Vesper Next Generation...
March 18, 2024